Growth of India's largest pharmaceutical company

Source: Xinkangjie 2014-09-24 according to the 2014 financial year report of sunpharma, at present, sunpharma products have been sold in more than 50 countries in the world, with 25 production bases in four continents, 14000 global partners, and a total of more than 1000 products sold Recently, sun pharmaceutical of India has reached an agreement with MSD of the United States The former agreed to pay 8000 US dollars to the latter in a phased manner to obtain tildrakizumab (anti-il-23p19), a phase III clinical McAb for the latter, which is used for the treatment of chronic plaque psoriasis This also marks a significant step for the Indian pharmaceutical company to move towards the world According to the agreement, sun pharmaceutical will obtain the full right to use the drug for all indications of human beings, while MSD will continue to promote all clinical development and regulatory activities, but funded by sun pharmaceutical After the product is approved for marketing, sun pharmaceutical will be responsible for regulatory activities, including follow-up opinions, pharmacovigilance, post marketing research, production and commercialization MSD will be eligible for regulatory and sales milestones and royalties for global sales of products For many Chinese, sun pharmaceutical is still a strange enterprise But it was the company that, at the beginning of this year, spent $4 billion to buy lambertino, which is famous for imitating Lipitor, from Japan's first three pharmaceutical companies This M & A has also become the largest transaction in the pharmaceutical sector in the Asia Pacific region this year The merger with rambsi in April this year made sunpharma the largest pharmaceutical company in India The combined market share of the two companies will be more than 9%, which will make sunpharma come out of the specialized pharmaceutical industry in the public's impression What the outside world doesn't know is that sun pharmaceutical started from specialty, and now sun pharmaceutical is the fifth largest specialty pharmaceutical enterprise in the world Its focus areas include neurology, psychiatry, cardiovascular, plastic surgery, ophthalmology, digestive, diabetes, urology and other departments Many of its specialty generic drugs have been sold well at home and abroad According to the 2014 financial year report of sunpharma, at present, sunpharma products have been sold in more than 50 countries, 25 production bases in four continents and 14000 global partners, with a total of more than 1000 products sold 2013 is the year of sun pharmaceutical's rise The financial year 2014 report shows that the company's revenue in 2013 was 162 billion rupees, an increase of 42% The profit was 71 billion rupees, up 45% year on year Sunpharma attributes its outstanding performance to global development Sales in the U.S market grew by 60% and in other countries, including India, by 25% Table 1 revenue of each business area of sun pharmaceutical in order to open up overseas market, sun pharmaceutical and American Intrexon company set up venture capital fund, mainly to develop controllable gene diagnosis and treatment field, especially ophthalmic medicine field In 2012, sunpharma also acquired URL, a generic pharmaceutical manufacturing enterprise located in the United States After the acquisition, not only enriched the product line, but also brought the production and market of the United States into the controllable scope of the enterprise As we all know, India is a global power of generic drugs, and it is India's patent policy and Indian pharmaceutical companies like sunpharma that support India's power of generic drugs According to some data, in 2012, the market size of global brand drugs and generic drugs reached US $589 billion and US $261 billion respectively, accounting for 61% and 27% of global total pharmaceutical revenue respectively By 2017, the market size of brand drugs will grow to $608-624 billion, while that of generic drugs will reach $421 billion and $432 billion The growth rate of generic drugs will far exceed that of brand drugs Sun pharmaceutical has begun to rub hands in the wave of global generic drugs Is China's generic drug company waking up? Let's see the approval of sun pharmaceutical in Anda Figure 1 the number of approved generic drugs of sun pharmaceutical in the United States anda (by treatment field)